Russell Investments Group
LAB icon

Russell Investments Group’s Standard BioTools LAB Stock Holding History

Russell Investments Group’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.9K Sell
21,634
-3,504
-14% -$4.24K ﹤0.01% 3624
2025
Q4 		$32.2K Buy
25,138
+117
+0.5% +$157 ﹤0.01% 3466
2025
Q3 		$32.5K Buy
25,021
+24,211
+2,989% +$31.7K ﹤0.01% 3434
2025
Q2 		$972 Buy
+810
New +$898 ﹤0.01% 3671
2025
Q1 		– Sell
-220
Closed -$385 – 3840
2024
Q4 		$385 Hold
220
– – ﹤0.01% 3633
2024
Q3 		$425 Hold
220
– – ﹤0.01% 3585
2024
Q2 		$389 Hold
220
– – ﹤0.01% 3518
2024
Q1 		$596 Buy
+220
New +$531 ﹤0.01% 3186
2020
Q4 		– Sell
-106,289
Closed -$788K – 3124
2020
Q3 		$788K Sell
106,289
-1,324,628
-93% -$9.14M ﹤0.01% 2169
2020
Q2 		$5.74M Sell
1,430,917
-5,840,328
-80% -$20.3M 0.01% 1019
2020
Q1 		$18.5M Buy
7,271,245
+1,411,413
+24% +$4.64M 0.05% 430
2019
Q4 		$20.4M Buy
5,859,832
+1,850,282
+46% +$6.51M 0.04% 536
2019
Q3 		$18.6M Sell
4,009,550
-1,428,479
-26% -$11.3M 0.04% 568
2019
Q2 		$67M Sell
5,438,029
-149,060
-3% -$1.9M 0.13% 192
2019
Q1 		$74.2M Buy
5,587,089
+423,877
+8% +$4.47M 0.14% 164
2018
Q4 		$44.5M Buy
5,163,212
+889,727
+21% +$6.93M 0.1% 231
2018
Q3 		$32M Sell
4,273,485
-121,465
-3% -$863K 0.06% 366
2018
Q2 		$26.2M Buy
4,394,950
+684,781
+18% +$3.9M 0.05% 417
2018
Q1 		$21.7M Sell
3,710,169
-121,070
-3% -$795K 0.04% 574
2017
Q4 		$23.6M Buy
3,831,239
+383,748
+11% +$2.1M 0.04% 565
2017
Q3 		$17.4M Buy
3,447,491
+1,099,072
+47% +$4.62M 0.03% 693
2017
Q2 		$9.48M Buy
2,348,419
+89,482
+4% +$424K 0.02% 942
2017
Q1 		$12.8M Buy
2,258,937
+19,725
+0.9% +$125K 0.02% 745
2016
Q4 		$16.1M Buy
+2,239,212
New +$14.1M 0.03% 641

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Russell Investments Group's LAB Position: Q1 2026 in Review

Russell Investments Group reduced its Standard BioTools (LAB) stake by 14% in Q1 2026, selling an estimated $4.24K and leaving 21,634 shares worth $19.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3624.

Russell Investments Group first reported a position in LAB in Q4 2016 and has held it in 24 quarters since. The position peaked at $74.2M in Q1 2019. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • Russell Investments Group held 21,634 shares of Standard BioTools worth $19.9K as of Q1 2026.
  • Russell Investments Group sold 3,504 Standard BioTools shares in Q1 2026, an estimated $4.24K.
  • Standard BioTools made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #3624 holding.
  • Russell Investments Group first reported a position in Standard BioTools in Q4 2016 and has held it in 24 quarters since.
  • Russell Investments Group's Standard BioTools position peaked at $74.2M in Q1 2019.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.